Understanding Lung Adenocarcinoma: A Silent Killer Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 80–85% of all cases, with lung adenocarcinoma (LUAD) being […]
Cervical Cancer Remains a Serious Global Health Challenge Cervical cancer is the second most common gynecologic cancer worldwide and remains a major cause of cancer-related death in women. In 2018 alone, an estimated 18.1 million […]
Understanding the Stakes: Lung Cancer and the PD-L1 Challenge Lung cancer is the most diagnosed cancer worldwide, with nearly two million new cases reported each year. Among its types, non-small cell lung cancer (NSCLC) dominates […]
A Fresh Approach to Treating Diffuse Large B-Cell Lymphoma (DLBCL) Diffuse large B-cell lymphoma (DLBCL) is the most common and aggressive type of non-Hodgkin lymphoma (NHL), a group of cancers that affect the lymphatic system. […]
Could CRELD2 Be a Key Biomarker in Triple-Negative Breast Cancer? A new study from researchers at Necmettin Erbakan University suggests that a specific protein, CRELD2, might help predict outcomes for patients with triple-negative breast cancer […]
Peer review is crucial in the scientific publishing process, as it ensures that research papers meet high-quality and accurate standards. Each month, the BiomolBiomed Editorial team recognizes a reviewer who has delivered outstanding and constructive […]
Lung cancer is the leading cause of cancer-related deaths globally, with nearly 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) accounts for approximately 80%–85% of all lung cancer cases. Most patients are diagnosed […]
For the past four decades, the 67 kDa laminin receptor (67LR) has been a central focus of cancer research, especially in the study of colorectal carcinoma. This receptor was hypothesized to consist of a complex […]
Low-grade glioma (LGG) belongs to a large class of gliomas, tumors that occur in the brain and spinal cord, with great intrinsic heterogeneity. In recent years, in-depth studies of the tumor microenvironment have made a […]
The urokinase plasminogen activator system is an important asset of cancer cells’ pro-metastatic arsenal, as its components coordinate the targeted degradation of the surrounding. Researchers from the Medical University of Plovdiv sought to explore whether […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH